To me, patient centricity is as fascinating a concept as it is contradictory. It is fascinating because it puts power into the hands of the patient. And it is contradictory because pharma does not like giving away power over its messages or processes. Pharma has traditionally never enjoyed interaction and has depended on ‘pushing’ messages across rather than having ‘conversations’. It probably also explains why we make do with medical reps who are not the sharpest knives in the drawer and scarcely invest in sharpening them.

Contact Us
Terms of Service
Privacy Statement

Facebook

Twitter

Youtube

Healthcare Trends

What ChrysCapital’s Takeover Of Novartis India Really Means

When ChrysCapital, one of India's oldest and largest homegrown...

Biological E. Limited appointments Manishkumar Munot as Chief Business Officer—Vaccines.

Manishkumar Munot has joined Biological E. Limited as Chief...

Big Pharma and the Obesity War – Science to Subpoenas

Two pharmaceutical giants are currently locked in a high-stakes...

Lifetime Value of a Patient: Why Indian Pharma must Transition from Product-centric Selling to Patient-centric Healthcare

Introduction For decades, the Indian pharmaceutical industry has measured success...

Simon Rosof has been appointed Head of Asia Pacific for Bayer Pharmaceuticals

Simon Rosof has been appointed Head of Asia Pacific...

Marketing

What ChrysCapital’s Takeover Of Novartis India Really Means

When ChrysCapital, one of India's oldest and largest homegrown...

Biological E. Limited appointments Manishkumar Munot as Chief Business Officer—Vaccines.

Manishkumar Munot has joined Biological E. Limited as Chief...

Big Pharma and the Obesity War – Science to Subpoenas

Two pharmaceutical giants are currently locked in a high-stakes...

Lifetime Value of a Patient: Why Indian Pharma must Transition from Product-centric Selling to Patient-centric Healthcare

Introduction For decades, the Indian pharmaceutical industry has measured success...

Simon Rosof has been appointed Head of Asia Pacific for Bayer Pharmaceuticals

Simon Rosof has been appointed Head of Asia Pacific...

Policies/Sales

What ChrysCapital’s Takeover Of Novartis India Really Means

When ChrysCapital, one of India's oldest and largest homegrown...

Biological E. Limited appointments Manishkumar Munot as Chief Business Officer—Vaccines.

Manishkumar Munot has joined Biological E. Limited as Chief...

Big Pharma and the Obesity War – Science to Subpoenas

Two pharmaceutical giants are currently locked in a high-stakes...

Lifetime Value of a Patient: Why Indian Pharma must Transition from Product-centric Selling to Patient-centric Healthcare

Introduction For decades, the Indian pharmaceutical industry has measured success...

Simon Rosof has been appointed Head of Asia Pacific for Bayer Pharmaceuticals

Simon Rosof has been appointed Head of Asia Pacific...

Strategy

What ChrysCapital’s Takeover Of Novartis India Really Means

When ChrysCapital, one of India's oldest and largest homegrown...

Biological E. Limited appointments Manishkumar Munot as Chief Business Officer—Vaccines.

Manishkumar Munot has joined Biological E. Limited as Chief...

Big Pharma and the Obesity War – Science to Subpoenas

Two pharmaceutical giants are currently locked in a high-stakes...

Lifetime Value of a Patient: Why Indian Pharma must Transition from Product-centric Selling to Patient-centric Healthcare

Introduction For decades, the Indian pharmaceutical industry has measured success...

Simon Rosof has been appointed Head of Asia Pacific for Bayer Pharmaceuticals

Simon Rosof has been appointed Head of Asia Pacific...

Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
- FFE+CEO RT
- BrandStorm
Solutions & Pricing
Partner

Hot topics

GSK Bets Big on Liver Disease: $1.2B Upfront for Boston Pharma’s MASH Drug

In a bold move to strengthen its hepatology pipeline,...

Indian Pharma in September 2025: Momentum, Disruption & Caution

Indian Pharma in September 2025: Momentum, Disruption & Caution By...

Will Omicron Wave be a Repeat Rx for Indian Pharma?

How had Indian Pharma responded to the challenges brought on by the Covid19 crisis and the inability to connect with doctors and other Rx influencers? Is it back to business-as-usual or have some companies learned from their mistakes and become digital savvy? How will Indian Pharma cope with the possibility of another lockdown and meeting restrictions looming in view of the rising Omicron wave?

Ashok Nair, Managing Director of Abbott India in Conversation with MedicinMan

Ashok Nair began his career as a Medical Rep...

Deep Bhandari: Human capital holds the highest value for organizations

DigiStorm 2018 was held on 11 September at the Lalit Ashok in Bangalore. The event was headlined by Prabir Jha – President & Global Chief People Officer, Cipla. Deep Bhandari – Editorial Board Member, MedicinMan, gives us the highlights of the post-lunch session.